Indacaterol + Mometasone + Glycopyrrolate

Uses of Indacaterol + Mometasone + Glycopyrrolate

This medication, belonging to the class of bronchodilators and corticosteroids, is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.

How Indacaterol + Mometasone + Glycopyrrolate Works

Indacaterol, a long-acting beta agonist (LABA), relaxes the muscles in the airways, making breathing easier. Mometasone, a corticosteroid, reduces inflammation in the airways, while glycopyrrolate, an anticholinergic, blocks the action of acetylcholine, further relaxing the airways.

Side Effects of Indacaterol + Mometasone + Glycopyrrolate

Common side effects may include headache, throat irritation, cough, and dry mouth. Less common but serious side effects can include increased heart rate, difficulty breathing, and allergic reactions. Consult a healthcare professional if any severe side effects occur.

Warnings

Kidney Limited Data

Limited data are available regarding the impact of this medication on kidney function. Consultation with a healthcare professional is recommended for individuals with kidney issues.

Alcohol Limited Data

Limited data are available regarding the interaction of this combination with alcohol. Caution is advised, and consultation with a healthcare professional is recommended before combining the two.

Pregnancy Limited Data

There is limited data on the safety of this combination during pregnancy. Consultation with a healthcare provider is recommended to assess potential risks and benefits.

Driving Use With Care

Caution is advised while driving or operating machinery, as this combination may cause dizziness or blurred vision. It is essential to assess individual response before engaging in activities that require alertness.

Liver Limited Data

Limited data are available on the effects of this combination on liver function. Caution is advised, especially in patients with liver conditions. Consultation with a healthcare professional is recommended.

Lactation Limited Data

Limited data are available regarding the safety of this combination during lactation. Consultation with a healthcare professional is advised to determine potential risks and benefits.

Written by , MD (Universiti Hasanuddin, Indonesia)

Reviewed by Dr Nur Syuhada binti Zulkifli, MD, Universiti Kebangsaan Malaysia (UKM).

  • Products

    Available medicines with Indacaterol + Mometasone + Glycopyrrolate
  •